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Pisa and Reggio Emilia, ItalyOBJECTIVES The aim of this study was to investigate the diagnostic performance of 99mTc-hexam-
ethypropylene amine oxime labeled autologous white blood cell (99mTc-HMPAO-WBC) scintigraphy in pa-
tients with suspected infections associated with cardiovascular implantable electronic devices (CIEDs).
BACKGROUND Early, deﬁnite recognition of CIED-related infections combined with accurate local-
ization and quantiﬁcation of disease burden is a prerequisite for optimal treatment strategies.
METHODS All 63 consecutive patients underwent clinical examination, blood chemistry, microbi-
ology, and echography of the cardiac region/venous pathway of the device. Final diagnosis of infection
was established in 32 of 63 patients and in 23 of 32 by microbiology.
RESULTS Sensitivity of 99mTc-HMPAO-WBC single-photon emission computed tomography/
computed tomography (SPECT/CT) was 94% for both detection and localization of CIED-associated infec-
tion. SPECT/CT imaging had a deﬁnite added diagnostic value over both planar and stand-alone SPECT.
Pocket infection was often associated with lead(s) involvement; the intracardiac portion of the lead(s)
more frequently exhibited 99mTc-HMPAO-WBC accumulation and presented the highest rate of compli-
cations, infectious endocarditis, and septic embolism. Two false negative cases and no false positive re-
sults were observed. None of the patients with negative 99mTc-HMPAO-WBC scintigraphy developed
CIED-related infection during follow-up of 12 months. Echography of the cardiac region/venous pathway
of the device had 90% speciﬁcity, but low sensitivity (81% when intracardiac lead[s] infection only was
considered). The Duke criteria had 31% sensitivity for the deﬁnite category (100% speciﬁcity) and 81% for
the deﬁnite and possible categories (77% speciﬁcity).
CONCLUSIONS 99mTc-HMPAO-WBC scintigraphy enabled the conﬁrmation of the presence of
CIED-associated infection, deﬁnition of the extent of device involvement, and detection of associated
complications. Moreover, 99mTc-HMPAO-WBC scintigraphy reliably excluded device-associated infection
during a febrile episode and sepsis, with 95% negative predictive value. (J Am Coll Cardiol Img
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1076se of cardiovascular implantable electronic
devices (CIEDs) has increased signiﬁ-
cantly over the past decade due to growing
evidence of improved quality of life and
survival among certain groups of patients (1); such
devices include the permanent pacemaker, the
implantable cardioverter-deﬁbrillator, and cardiac
resynchronization therapy. Associated complica-
tions, particularly infections, have risen dispropor-
tionally higher than the growth of newly implanted
devices (2). The rate of CIED-related infections
varies widely between 1% and 7% (3), with signiﬁ-
cant morbidity and mortality, especially in cases of
delayed diagnosis (4). Therefore, strategies to
facilitate early diagnosis are crucial for a favorable
clinical outcome.
Diagnostic workup of CIED-related infections is
problematic because patients can present with a va-
riety of manifestations, including subtle signs ofeled
n
puted
yl
beled
ll
ice
y
issionsystemic or local infection (5). The decision
of whether to medically treat the infection
and/or to remove the device represents a
further crucial point, because it implies
evaluation of response to antimicrobial
therapy and selection of the optimal time to
re-implant (6).
Final diagnosis of CIED-associated
infection is generally based on microbio-
logical tests (blood cultures and culture of
material from exposed sites of implanta-
tion) and ultrasound evaluation of the
cardiac region (either transthoracic and
transesophageal) and of the venous path-
way of the device. These tests constitute thebasis for deﬁning a patient’s risk for CIED-related
infection according to the Duke criteria (7). How-
ever, in cases of CIED-related infection, the Duke
criteria, originally developed for the diagnosis of in-
fectious endocarditis, may be inadequate; even with
the addition of clinical parameters (8), the possibility
of missing the presence of, and/or underestimating
the extent of, infection remains high (5).
There is growing evidence that positron emission
tomography used with computed tomography with
18F-labeled ﬂuorodeoxyglucose ([18F]FDG PET/
CT) improves the diagnosis of CIED-related in-
fection (9–11). On the other hand, in the era of high
spatial resolution hybrid systems for single-photon
emission computed tomography (SPECT) used
with CT (SPECT/CT), scintigraphy with radio-
labeled autologous white blood cells (WBCs)
represents a valuable option for imaging patients
with suspected CIED-related infection, as already
demonstrated in a number of other clinicalconditions, such as native and prosthetic valve–
related endocarditis (12). These functional imaging
modalities are based on the ability to detect and
localize metabolically active cells, such as those
involved in inﬂammation and infection. By following
the pattern of radiolabeled WBC accumulation over
time and by using well-deﬁned criteria for interpre-
tation (13), it is possible to discriminate active
infection from inﬂammatory changes (e.g., post-
surgical changes, foreign-body reactions) and to
deﬁne the extent of active infection.
This study investigated the diagnostic perfor-
mance of 99mTc-hexamethypropylene amine oxime–
labeled autologous WBCs (99mTc-HMPAO-WBC)
SPECT/CT in consecutive patients referred to the
Division of Cardiology or Infectious Diseases, Uni-
versity Hospital of Pisa, Pisa, Italy, for suspected
CIED-related infection.
METHODS
Study design and patient population. Between June
2007 and June 2011, a total of 63 consecutive patients
(47 men and 16 women; mean age 68.6 13.9 years;
median age 70 years [range 27 to 87 years]) were
referred for scintigraphywith radiolabeled autologous
WBCs (99mTc-HMPAO-WBC), recording both
planar and SPECT/CT acquisitions, and results were
retrospectively evaluated. All patients provided
informed consent to undergo the procedure.Workup
consisted of clinical examination, blood chemistry
includingWBCcount,C-reactive protein, erythrocyte
sedimentation rate, acute phase proteins, electropho-
resis, urinalysis, transthoracic and transesophageal
echocardiography, and ultrasound evaluation of the
venous pathway. Three sets of peripheral venous
blood samples were obtained for cultures, including at
least 1 aerobic and 1 anaerobic sample (14). Scintig-
raphy was performed in all cases of unconﬁrmed
diagnosis of CIED-related infection at the end of the
described conventional procedures. After 99mTc-
HMPAO-WBC, treatment was decided on the basis
of the degree of certainty of diagnosis of CIED-
related infection as results of conventional tests and
clinical guidelines, as follows: 35 patients were treated
with device extraction followed by antimicrobial
therapy, as previously described (15); 9 patients, with
antimicrobial therapy alone; and 11 patients, with
other disease-speciﬁc surgical procedures. Eight pa-
tients received no treatment. In patients with a high
clinical suspicion of CIED-related infection based
on either a positive blood culture (n ¼ 12) or diag-
nostic echocardiography (n ¼ 7), the results of
99mTc-HMPAO-WBCwere not used to guide ﬁnal
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1077decisions on management because these patients
underwent device extraction followed by antimi-
crobial therapy (Fig. 1). In cases of antimicrobial
therapy alone or no treatment, clinical follow-up of
at least 12 months was available for ﬁnal classiﬁca-
tion. All 9 patients who underwent antimicrobial
therapy alone had repeat 99mTc-HMPAO-WBC
scintigraphy at the end of treatment. A total of 75
examinations were therefore performed (63 baseline
and 12 follow-up studies); in particular, 9 patients
had repeat studies (6 with one follow-up scan after
6 months, 3 with two follow-up scans at 6 to 9 and
12 months).
The main clinical features of patients and types of
devices implanted are reported in Table 1. Final
diagnosis of CIED-associated infection was estab-
lished in 32 of 63 patients (Table 2); in 23 of 32 pa-
tients, diagnosis was conﬁrmed by microbiology after
extraction of the device. In the remaining 9 of
32 cases, diagnosis was obtained with clinical follow-
up of at least 12months based on negative ﬁndings on
clinical examination, sequential blood tests, trans-
thoracic and transesophageal echocardiography, ul-
trasound evaluation of the venous pathway, and
99mTc-HMPAO-WBC scintigraphy following an-
timicrobial treatment.
Staphylococcus spp. was the microorganism most
frequently involved in CIED-associated infection
(12 of 32), followed by Streptococcus spp. (8 of 32);
Enterococcus spp. (3 of 32); Enterobacteriaceae,
Micrococcus, and Candida spp. (2 patients each); and
Pseudomonas aeruginosa, Acinetobacter baumanni, and
Propionibacter acnes (1 patient each).BC +
n =16
BC -
n =16
ECHO -
n = 5
(n = 2)(n = 3) (n =7)(n = 20)
ECHO -
n = 7
ECHO +
n = 20
Final Diagnosis of
CIED-related Infection
n = 32
No CIED
Removal
No CIED RemovalCIED Removal
Figure 1. Clinical Management
Clinical management of patients included in the study according to the
related infection (left panel) or exclusion of CIED-related infection (rigInfection occurred most frequently early after
implantation (6 of 8 patients evaluated at <1 month
and 5 of 13 cases evaluated at 1 to 3 months after
implantation). Semi-late and late infections were
observed in 8 of 18 and in 13 of 22 patients,
respectively (Table 1). Nineteen of 32 infections
occurred after the second implantation procedure.
Radiolabeling and acquisition protocol. Autologous
radiolabeled WBCs were prepared according to the
European Association of Nuclear Medicine guide-
lines for labeling WBCs with 99mTc-HMPAO
(16,17). Radiolabeling efﬁciency was always be-
tween 70% and 85%; viability of the radiolabeled
WBCs was always evaluated by the Tripan
blue exclusion test before reinfusion. Radiolabeling
of WBCs with 99mTc was preferred over the radi-
olabeling with 111In for both radiation safety
(0.017 mSv/MBq with a recommended adminis-
tered activity of 185 to 370 MBq for 99mTc vs.
0.59 mSv/MBq with a recommended administered
activity of 10 to 18.5 MBq for 111In) (13,18) and
imaging quality when performing SPECT/CT.
Whole-body and spot planar images were ob-
tained after 30 min, then 4 to 6 h (early images)
and 20 to 24 h (delayed images) after reinfusion
of 370 to 555 MBq of 99mTc-HMPAO-WBC.
SPECT/CT of the chest was performed in all pa-
tients at 6 h and repeated at 24 h in cases of negative
or doubtful imaging at 6 h. Images were acquired
using adual-head, variable-angle SPECT/CTgamma
camera (Hawkeye andDiscovery 670,GEHealthcare,
Little Chalfont, United Kingdom) as previously
reported (12). Both CT attenuation-corrected(n = 8) (n = 4)(n =19)
ECHO -
n = 27
ECHO +
n = 4
BC +
n =12
BC -
n =19
Final Diagnosis of
No CIED-related Infection
n = 31
No CIED RemovalCIED Removal CIED Removal
ﬁnal diagnosis of cardiovascular implantable electronic device (CIED)-
ht panel). BC ¼ blood culture; ECHO ¼ echocardiography.
Table 1. Types of Cardiac Devices and Main Clinical
Features of the Patients Included in the Study (N [ 63)
Device type
1-chamber PM 30 (48)
Infection 12/30 (40)
2-chamber PM 17 (27)
Infection 7/17 (41)
Temporary PM 2 (3)
Infection 1/2 (50)
1-chamber ICD 9 (14)
Infection 7/9 (78)
2-chamber ICD 5 (8)
Infection 3/5 (60)
Risk factors
Diabetes 17 (27)
Renal failure 11 (17)
Long-term corticoid 7 (11)
Previous infection 8 (13)
Recent invasive procedure 30 (48)
Fever 35 (55)
Time from device implantation, months
#1 10 (16)
Infection 6/10 (60)
>1–3 13 (21)
Infection 5/13 (38)
>3–12 18 (28)
Infection 8/18 (44)
>12 22 (35)
Infection 13/22 (59)
Local inﬂammation signs/symptoms
Pain 16 (25)
Tenderness 14 (22)
Erythema 8 (13)
Purulent drainage 3 (5)
Blood test
ESR 49 (77)
PCR 42 (67)
Leukocytosis 29 (46)
Microbiological blood culture results
Positive 28 (44)
Negative 37 (56)*
Values are n (%). *During antibiotic therapy in 29 of 63 patients; 5 patients
presented with either positive EC or pocket culture.
CRP ¼ C-reactive protein; EC ¼ electrocatether; ESR ¼ erythrocyte sedi-
mentation rate; ICD ¼ implantable cardioverter deﬁbrillator; PCR ¼ poly-
merase chain reaction; PM ¼ pacemaker.
Table 2. Results of Microbiological Evaluation/Culture
Results Before and After Device Removal in Patients With
CIED-Associated Infection (n [ 32)
Blood culture
Positive 16 (50)
Negative 16 (50)*
Microbiology after device removaly 23 (74)
Values are n (%). *During antibiotic therapy in 8 of 16 patients. yExtraction was
performed in a total of 35 patients, including 11 in whom CIED-associated
infection resolved; 9 of 32 patients with CIED infection did not undergo
extraction.
CIED ¼ cardiovascular implantable electronic devices.
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1078and -noncorrected SPECT images were evaluated in
the coronal, transaxial, and sagittal planes, as well as in
tridimensional maximal-intensity projection cinemode. Matching pairs of x-ray transmission and
radionuclide emission images were fused using
Xeleris software (GE Healthcare), and hybrid im-
ages of overlying transmission and emission data
were generated.
Interpretation criteria. All images were re-
evaluated, independently, by 2 experienced nuclear
physicians aware of the patients’ clinical history and
of the results of prior conventional imaging. Images
were ﬁrst visually inspected to exclude misregistra-
tion between the SPECT and the CT components.
Thereafter, for all sets of images, the presence and
location of any focus of abnormal radioactivity
accumulation indicating infection was evaluated.
The scintigraphic studies were classiﬁed as negative
when no sites of abnormal uptake were observed in
the SPECT/CT images, or as positive for infection
when at least 1 focus of abnormal uptake charac-
terized by a time-dependent increase in radioactivity
between early and delayed images was observed
(13). When present, focal uptake indicating infec-
tion was further classiﬁed as: 1) isolated pocket
infection; 2) isolated lead infection at either the
intravascular or the intracardiac portion of the lead;
3) pocket and lead infection (either intravascular or
intracardiac portion); 4) concomitant endocarditis;
5) extracardiac site(s) of infection consistent with
embolism; or 6) other infection.
Data analysis. Results of 99mTc-HMPAO-WBC
scintigraphy were correlated with those of ultraso-
nography (echocardiography þ soft tissue/venous
ultrasound), with the Duke criteria classiﬁcation, and
with ﬁnal microbiological or clinical diagnosis.
Furthermore, the ability to identify concomitant
endocarditis as well as septic emboli was considered
in the assessment of the ability of 99mTc -HMPAO-
WBC scintigraphy to deﬁne disease burden.
For site-based analysis, results of planar, stand-
alone SPECT, and SPECT/CT imaging were
compared. Stand-alone SPECT and SPECT/CT
were considered to have a deﬁnite added value if they
Figure 2. 99mTc-HMPAO-WBC of CIED-Related Infection Involving the Pocket
(A) Tecnitium-99m–hexamethyl propylene amine oxime–labeled autologous white blood cell (99mTc-HMPAO-WBC) scintigraphy in a patient
with localized pocket infection, with transaxial slices shown at different levels (computed tomography [CT] sections in upper panels, cor-
responding fused single-photon emission computed tomography [SPECT]/CT sections in lower panels). Obvious focal accumulation of
radiolabeled WBCs at the pocket. (B) A normal scintigraphic pattern, shown for comparison.
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1079provided data that could not be obtained from planar
imaging concerning the presence of infection or its
precise location. The contribution of SPECT/CT
was considered with special attention to the possibility
of anatomically localizing the exact site of infection.
Statistical analysis. All values are expressed as me-
dian and range, as is standard for nonparametric
data. The Pearson chi-square test was employed for
comparing nominal data between groups. Interob-
server agreement was determined and expressed in a
weighted kappa, which corrects for agreement
by chance. The higher the kappa, the higher
the agreement, with a maximum value of 1.0Figure 3. 99mTc-HMPAO-WBC of Ascertained CIED-Related Infection
(A) 99mTc-HMPAO-WBC scintigraphy in a patient with clinically ascertaine
sections in upper panels, corresponding fused SPECT/CT sections in lo
involving both the pocket and the intravascular portion of the lead. (B) A
as in Figure 2.(<0.0 ¼ no agreement; 0.0 to 0.19 ¼ poor agree-
ment; 0.20 to 0.39 ¼ fair agreement; 0.40 to
0.59 ¼ moderate agreement; 0.60 to 0.79 ¼ sub-
stantial agreement; and 0.80 to 1.00 ¼ almost
perfect agreement) (19). In cases of disagreement
between the 2 observers, a ﬁnal consensus reading
was performed. Sensitivity, speciﬁcity, accuracy, and
positive and negative predictive values of echocar-
diography, Duke criteria, and 99mTc-HMPAO-
WBC planar, stand-alone SPECT, and SPECT/
CT imaging were calculated based on the ﬁnal
diagnosis, with 95% conﬁdence intervals (CIs), and
compared using the McNemar test.Involving the Pocket and the Intravascular Portion of the Lead
d pocket infection, with transaxial slices shown at different levels (CT
wer panels). Obvious focal accumulation of radiolabeled WBCs
normal scintigraphic pattern is shown for comparison. Abbreviations
Figure 4. 99mTc-HMPAO-WBC of Suspected CIED-Related Infection at the Intracardiac Lead
99mTc-HMPAO-WBC scintigraphy in a patient with suspected CIED infection. Obvious focal accumulation of radiolabeled WBCs at the heart
region in the SPECT coronal (A, left panel) and transaxial images (B, left panel); fused SPECT/CT sections exactly localized the focus of
infection at the intracardiac lead (right panels). CT images are shown in the middle panels. Abbreviations as in Figure 2.
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1080RESULTS
99mTc-HMPAO-WBC scintigraphy in patientswith CIED-
related infections. By adopting the interpretation
criteria described earlier for scintigraphic detection
of infection evaluating the best-performing imaging,
that is, SPECT/CT, it was possible to classify all of
the scans as either frankly positive or frankly negative
and therefore without equivocal result. The kappa
value for interobserver agreement was 0.951 (95%
CI: 0.909 to 1.000).
The 99mTc-HMPAO-WBC scans were totally
negative in 22 of 63 cases. At least 1 area with focal
accumulation of the radiolabeled WBCs was
detected in the remaining 41 patients.
99mTc-HMPAO-WBC scintigraphy was true
positive in 30 of 32 patients with ﬁnal diagnosis of
CIED-associated infection (94%). The two false
negative scans were observed in patients with
CIED-related infections caused by Candida and
Enterococcus spp. (ﬁnal diagnosis obtained by culture
of the leads). One of these 2 patients also had
false negative echocardiography and was classiﬁed as
rejected infection according to the Duke criteria; the
case of second false negative scintigraphy was true
positive on echocardiography and was classiﬁed as
deﬁnite infection according to the Duke criteria.
Both of the latter patients were on antimicrobialtherapy at the time of scintigraphy. There were no
false positive scans for CIED-related infection.
Figure 2 shows an example of positive 99mTc-
HMPAO-WBC scintigraphy for infection localized
at the pocket. Figures 3 and 4 show the scinti-
graphic pattern of infection localized at the intra-
vascular and intracardiac portions of the leads,
respectively.
SPECT/CT acquisition provided higher accuracy
both for detecting infection and for localizing 99mTc-
HMPAO-WBC accumulation at any portion of
the device, at the heart valves, or at other noncardiac
sites of infection in the thoracic andmediastinal space.
SPECT/CT acquisitions changed the ﬁnal classiﬁ-
cation of the scan from negative to positive for CIED-
associated infection in 15 of 32 of the cases compared
with the standard planar and 9 of 32 compared with
SPECT-alone acquisition (chi-square: 4.5; p ¼ 0.03)
(Table 3). No false positive ﬁndings due to artefact
were detected in either the attenuation-corrected or
non–attenuation-corrected images.
Table 4 summarizes the results of 99mTc-
HMPAO-WBC scintigraphy (considering the best
nuclear imaging technique, i.e., SPECT/CT), of
echocardiography, and of classiﬁcation according to
the Duke criteria in the cases of a ﬁnal diagnosis of
CIED-related infection. Table 5 correlates the re-
sults of 99mTc-HMPAO-WBC scintigraphy with
Table 3. Results and Diagnostic Performance of 99mTc-HMPAO-WBC Planar, SPECT, and SPECT/CT Acquisitions in Patients
With CIED-Associated Infection (n [ 32)
Planar SPECT SPECT/CT
Result, n/N
Positive for CIED 15/32 21/32 30/32
Doubtful for CIED infection 11/32 9/32 –
Negative for CIED infection 6/32 2/32 2/32
Correct extent for device infection 12/32 21/32 30/32
Correct exclusion device involvement 36/43* 42/43 43/43
Correct detection of embolism 12/18y 13/18y 15/18y
Correct detection of IE 3/6 4/6 6/6
Positive for other infections 9/15 13/15 15/15
Correct extent for other sites of infection 7/15 11/15 15/15
Diagnostic performance, 95% CIz
Sensitivity 53.1 (40.2–65.6) 71.9 (58.9–82.1) 93.7 (83.9–98)
Speciﬁcity 83.9 (72–91.5) 96.8 (87.9–99.4) 100 (92.8–100)
Accuracy 68.3 (55.2–79.1) 84.1 (72.3–91.7) 96.8 (88–99.4)
Positive predictive value 77.3 (64.7–86.5) 95.8 (86.6–99) 100 (92.8–100)
Negative predictive value 63.4 (50.3–74.9) 76.9 (64.3–86.2) 93.9 (84.1–98.1)
*Including 5 false positive cases due to sternal osteomyelitis and mediastinitis. yIncluding 3 false negative cases due to ophthalmitis and cerebral infection. zPlanar
versus SPECT: chi-square: 0.4, p ¼ 0.5; planar versus SPECT/CT: chi-square: 3.5, p ¼ 0.06; and SPECT versus SPECT/CT: chi-square ¼ 4.5, p ¼ 0.03 (McNemar test).
99mTc-HMPAO-WBC ¼ Tecnitium-99m–hexamethyl propylene amine oxime–labeled autologous white blood cell; CI ¼ conﬁdence interval; CT ¼ computed
tomography; IE ¼ infectious endocarditis; SPECT ¼ single-photon emission CT.
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1081the results of echocardiography and with the Duke
classiﬁcation, stratifying the patients according to the
site of radiolabeled WBC accumulation, as follows:
at the pocket, at the intravascular and/or intracardiac
portion of the lead(s), and at both the pocket and the
lead(s). Sites of 99mTc-HMPAO-WBCs accumu-
lation consistent with additional infections (n ¼ 38)
are also indicated. Particular attention was paid to the
identiﬁcation of concomitant infectious endocarditis
(6 cases) (Fig. 5) and distant septic embolism
(osteomyelitis, n ¼ 6; vascular graft infection and
lung infection, n ¼ 4 each; and septic embolism in
the spleen, n ¼ 1). Septic embolism causing oph-
thalmitis or cerebral infection (1 case each), detected
on CT, remained undiagnosed on radiolabeled
WBC scanning.
Blood cultures. Blood cultures were positive in only
28 of 63 of the patients (16 of 32 of the cases of
conﬁrmed CIED-related infection); 28 of 35 of the
blood culture–negative patients with CIED-
associated infection were on antimicrobial treat-
ment at the time of assessment. All 5 cases of
CIED-associated infection with positive blood cul-
ture and negative transesophageal echocardiography
and intact pocket had true positive 99mTc-
HMPAO-WBC SPECT/CT examinations.99mTc-HMPAO-WBC SPECT/CT ruled out
device involvement during a febrile episode and
sepsis (20 of 63 with positive blood culture),
correctly excluding the presence of device involve-
ment in 31 of 63 cases.
99mTc-HMPAO-WBC scintigraphy in patients without
CIED-related infection. As to the 11 baseline scans
showing focal accumulation of radiolabeled WBCs
in patients without CIED-related infection, scin-
tigraphy actually detected alternative sites of infec-
tion, with sensitivity and speciﬁcity of 93% and
91%, respectively) (Table 6). These patients were
subsequently treated according to standard pro-
cedures as indicated for each clinical condition, and
none, including patients with positive blood cul-
tures, developed CIED-related infection during
follow-up.
Follow-up studies. On follow-up studies performed
6 to 9 months after baseline scintigraphy, all of the
sites of radiolabeled WBC accumulation were
resolved in 7 of 9 patients, thus allowing for the
discontinuation of antimicrobial treatment. In the
remaining 2 patients, 99mTc-HMPAO-WBC posi-
tivity resulted in prolonged medical treatment, which
was stopped only after normal ﬁndings on a third
99mTc-HMPAO-WBC scintigraphy performed 6
Table 4. Results of 99mTc-HMPAO-WBC Scintigraphy, Echocardiography, and Duke Criteria According to the Final Diagnosis
of CIED Infection With All Examinations Performed at Baseline*
99mTc-HMPAO-WBC Echocardiography
Duke Criteria
Deﬁnite Possible Rejected
CIED infection (n ¼ 32) 10/32 16/32 6/32
Positive 30/32 20/32
Negative 2/32 12/32
No CIED infection (n ¼ 31) 0/31 8/31 23/31
Positive 0/31 4/31
Negative 31/31 27/31
Diagnostic performance, 95% CI
Sensitivity 93.7 (83.9–98) 62.5 (49.4–74.1) 31.3y (20.5–44.3) 81.3 (69–89.6) –
Speciﬁcity 100 (92.8–100) 87.1 (75.7–93.8) 100y (92.8–100) 74.2z (61.4–84) –
Accuracy 96.8 (88–99.4) 74.6 (61.8–84.4) 65.1 (51.9–76.4) 52.4z (65.2–86.9) –
Positive predictive value 100 (92.8–100) 83.3 (71.4–91.1) 100y (92.8–100) 76.5z (63.8–85.9) –
Negative predictive value 93.9 (84.1–98.1) 69.2 (56.2–79.9) 58.5y (45.4–70.5) 79.3z (66.9–88.1) –
*99mTc-HMPAO-WBC versus echocardiography: chi-square: 2.6, p ¼ 0.1; 99mTc-HMPAO-WBC versus Duke Criteria considering as positive for IE only the “deﬁnite”
category: chi-square: 20, p < 0.001; 99mTc-HMPAO-WBC versus Duke Criteria considering as positive for IE both the deﬁnite and possible categories: chi-square: ¼ 1.3,
p ¼ 0.25 (McNemar test). yConsidering as positive for IE the only deﬁnite category. zConsidering as positive for IE both the deﬁnite and possible categories.
Abbreviations as in Table 3.
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1082months later. CIED infection did not recur in any of
these patients during subsequent follow-up.DISCUSS ION
Infections of CIEDs are associated with signiﬁcant
morbidity and a high death rate, particularly
in the presence of endovascular infection (20%)
(6,20). The incremental cost for managing CIED
infection has been estimated to be about $28,676 to
$53,349 (21), nearly one-half of this amount being
due to intensive care procedures (4). Furthermore,
device-replacement procedures, which are periodi-
cally necessary for battery depletion or for upgrad-
ing, are associated with infection rates higher than
those occurring after the initial implantation (3).
Early, deﬁnite recognition of CIED infection
combinedwith accurate localization andquantiﬁcation
of disease burden could provide a rational basis for
adopting optimal treatment strategies that have so far
not been sufﬁciently deﬁned.
In this work we evaluated a consecutive series of
patients in whom the suspicion of CIED infection
had been raised on clinical grounds. All patients
underwent 99mTc-HMPAO-WBC scintigraphy
with the purpose of validating the utility of this
procedure in conﬁrming CIED infection and in
deﬁning disease burden, the ﬁnal diagnosis being
obtained either by microbiology in 23 of 32 or withclinical follow-up of at least 12 months in the
remaining cases.
99mTc-HMPAO-WBC scintigraphy had 94%
sensitivity, and no false positive results were found,
thus conﬁrming the validity of the interpretation
criteria adopted (increasing radiolabeled WBC
recruitment over time at infection sites) as a diag-
nostic parameter enhancing speciﬁcity (16).
Conversely, the 2 false negative cases of 99mTc-
HMPAO-WBC scintigraphy observed in our
series were most likely due to infection caused by
low-WBC-recruiting microorganisms (22–24), as
Candida and Enterococcus strains were isolated in the
2 patients with conﬁrmed CIED infection in whom
99mTc-HMPAO-WBC scintigraphy was negative.
Therefore, when infections sustained by such mi-
croorganisms are suspected, discontinuation of
antimicrobial treatment should be considered for
the enhancement of the diagnostic performances of
99mTc-HMPAO-WBC scintigraphy.
The 99mTc-HMPAO-WBC SPECT/CT im-
ages aided not only in diagnosing infection but also
in deﬁning the infection burden, in particular by
distinguishing patients with infection limited to
either the pocket or the lead(s) from patients with
more severe infection involving both the pocket and
the lead(s), or other sites of infection in some
patients.
The intracardiac portion of the lead(s) was the
site more frequently exhibiting radiolabeled WBC
Table 5. Results of 99mTc-HMPAO-WBC Scintigraphy, Echocardiography and Duke Criteria According to the Final Diagnosis for All the Exams
Performed at Baseline, Classiﬁed According to the Site of Radiolabeled WBCs Accumulation at Scintigraphy
Pocket Infection Leads Infection Pocket D Lead Infection
CIED infections
(n ¼ 32)
Intravascular Intracardiac Both leads Intravascular Intracardiac Both leads Other
infections
99mTc-HMPAO-WBC
accumulation
1 1 18*y 2 2 4* 2 15
Echo pos 14z 2 2 2 3
neg 1 1 8z 2 2 12
Duke criteria Deﬁnite 8 3
Possible 13 3 3
Rejected 1 2 2 12
*With concomitant IE and/or extracardiac localization for a total of 6 cases (*) and 15 cases (y). zIncluding 1 cases of FN at WBC scan. In the images the yellow line represents the heart region, the
red line represents the component of the device showing radiolabeled WBCs accumulation at scintigraphy.
FN ¼ false negative; Pos ¼ positive; Neg ¼ negative; other abbreviations as in Tables 2 and 3.
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1083accumulation (n ¼ 18); these cases were also more
frequently associated with complications such as
infectious endocarditis (n ¼ 6) and/or septic em-
bolism (n ¼ 15). The higher prevalence of infection
of the intracardiac portion of the lead(s) over theFigure 5. 99mTc-HMPAO-WBC of Suspected CIED-Related Infection a
99mTc-HMPAO-WBC (A) coronal images and (B and C) transaxial image
blood culture and fever 3 months after mitral valve replacement. SPECT
at both the intracardiac leads (A and B) and the mitral valve mechanica
CT images, in the middle panels. Abbreviations as in Figure 2.surgical pocket is consistent with the relatively high
prevalence of semi-late and late infections in this
patient population, similar to data reported in the
literature, due to slowly progressing, implant-related
infection (25). Indeed, localized pocket infectiont the Intracardiac Leads and Mitral Valve Mechanical Prosthesis
s at different levels in a patient with CIED presenting with positive
images (left panels) depict focal accumulation of 99mTc-HMPAO-WBC
l prosthesis (C). SPECT/CT images are shown in the right panels, and
Table 6. Results on 99mTc-HMPAO-WBC Scintigraphy in
Patients With Suspected CIED Infection in Whom Scintigraphy
Detected Alternative Sites of Infection
Type of Infection
Osteomyelitis* 5
Vascular graft infection 2
Mediastinitis 2
Lung infection 2
Cholecystitis 2
*Including 2 cases of spondylodiscitis.
Abbreviations as in Table 3.
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1084was found in just 1 patient, while in all of the other
cases, infection of the pocket had involvement of
lead(s). An important feature of 99mTc-HMPAO-
WBC scintigraphy is therefore its unique ability,
shared only with PET/CT, to detect all sites of
infection with a single examination, considering the
frequent underestimation of the infection burden
based on clinical signs alone (26).
As is standard in cases of suspected CIED-
associated infection, all patients included in this
study underwent echography of the cardiac region
and of the venous pathway of the device as a ﬁrst-
line diagnostic test. In this group of patients,
echocardiography had high speciﬁcity (90%), but
relatively low sensitivity, for diagnosing CIED
infection (63%). The echocardiographic ﬁnding of
vegetations at the distal part of the lead typical for
infection (27) was detected in 9 of 32 patients with
conﬁrmed infection. On the other hand, in 4 of
31 patients who were eventually classiﬁed as not
having infection, a lead-associated mass, possibly of
thrombotic nature, was also detected, in line with a
previous report (28). Moreover, in 12 of 32 patients
with a ﬁnal diagnosis of CIED infection, trans-
esophageal echocardiography failed to visualize a
mass adherent to the intracardiac lead, thus con-
ﬁrming that a negative echocardiogram does not
exclude lead infection (29). In 6 of 12 cases of
negative echocardiography, 99mTc-HMPAO-WBC
SPECT/CT detected infection, which was localized
to the intravascular portion of the lead(s) and/or to
the surgical pocket (Table 4). Therefore, when
echocardiographic ﬁndings were considered in pa-
tients with intracardiac infection (n ¼ 26), sensi-
tivity increased to 81%.
Sensitivity of the Duke criteria was 31% in the
patients classiﬁed in the deﬁnite category (with
100% speciﬁcity), increasing to 81% when both the
deﬁnite and the possible categories were considered
(with 74% speciﬁcity). This relatively low sensitivityis not surprising because the Duke criteria were
originally developed for infectious endocarditis, and
several of the minor Duke criteria are not applicable
in this setting.
The results obtained in this study demonstrate
that SPECT/CT imaging with radiolabeled WBCs
in patients with suspected CIED infection increases
the detection rate of infection and allows accurate
assessment of disease burden. In patients with
infection of a left ventricular assist device and/or
valve, radiolabeled WBC SPECT/CT has been
shown to determine the precise anatomic location
and extension of a suspected infection, thus
affecting the management of these patients (12,30).
High diagnostic accuracy in patients with such a
condition has been observed also with the use
of PET/CT with [18F]FDG, particularly for ruling
out involvement of the devices during febrile epi-
sodes (31) and for deﬁning the embolic burden
in the presence of ascertained infection (32). A
more recent report encourages the use of [18F]FDG
PET/CT also in cases of early device-related
infection (10).
However, despite its high resolution, this tech-
nique is still limited by the lack of a suitable infection-
speciﬁc radiopharmaceutical agent. In fact, the
enhanced glucose consumption that causes increased
[18F]FDG uptake at infectious sites (for the presence
of activatedWBCs, monocyte-macrophages [33,34],
and CD4þ T lymphocytes [35]), can also occur in a
number of noninfectious, inﬂammatory conditions
(36) and in post-surgical changes (37).
The higher speciﬁcity of 99mTc-HMPAO-WBC
scintigraphy observed in our study when employing
SPECT/CT imaging (with spatial resolution better
than that with planar or stand-alone SPECT)
enabled precise deﬁnition of the disease burden,
therefore allowing risk stratiﬁcation and decision
making. In fact, similar to ﬁndings observed with
[18F]FDG PET/CT, a negative scan has consis-
tently been associated with a favorable clinical
outcome when antimicrobial therapy alone was
initiated. Indeed, a negative 99mTc-HMPAO-
WBC SPECT/CT might be used as a guide for
clinicians in choosing the most suitable, that is,
conservative, treatment (antimicrobial agents alone,
or removal of only the generator) versus full hard-
ware extraction.
Study limitations. Although WBC imaging is a
relatively more complex procedure compared with
[18F]FDG PET/CT both in terms of radiophar-
maceutical preparation, which includes blood
manipulation, and imaging acquisition, which re-
quires multiple scans at different time points, we
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1085believe that when differentiation between active
infection and inﬂammation is crucial, 99mTc-
HMPAO-WBC should be considered the method
of choice.
CONCLUS IONS
99mTc-HMPAO-WBC scintigraphy with SPECT/
CT acquisition of the chest in patients with a high
clinical suspicion of CIED infection enabled conﬁr-
mation of the presence of infection, deﬁnition of the
extent of device involvement, and detection of asso-
ciated complications such as infectious endocarditisand septic embolism. In addition, 99mTc-HMPAO-
WBC scintigraphy was helpful for excluding the
presence of device-related infection during a febrile
episode and sepsis, with a 95% negative predictive
value. Demonstration of the impact of functional
imaging on the overall healthcare costs of the
clinical management of CIED on a large scale
represents the next challenge.
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